Advisors Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $120K | Sell |
633
-1,014
| -62% | -$177K | ﹤0.01% | 1228 |
|
|
2025
Q4 | $280K | Sell |
1,647
-935
| -36% | -$143K | ﹤0.01% | 1080 |
|
|
2025
Q3 | $340K | Sell |
2,582
-196
| -7% | -$23.5K | 0.01% | 1037 |
|
|
2025
Q2 | $295K | Sell |
2,778
-788
| -22% | -$85.6K | 0.01% | 1057 |
|
|
2025
Q1 | $443K | Sell |
3,566
-716
| -17% | -$93.4K | 0.01% | 962 |
|
|
2024
Q4 | $527K | Sell |
4,282
-5,342
| -56% | -$630K | 0.01% | 910 |
|
|
2024
Q3 | $1.07M | Buy |
9,624
+364
| +4% | +$39.9K | 0.02% | 718 |
|
|
2024
Q2 | $988K | Sell |
9,260
-462
| -5% | -$50.8K | 0.02% | 734 |
|
|
2024
Q1 | $1.17M | Buy |
9,722
+819
| +9% | +$100K | 0.02% | 701 |
|
|
2023
Q4 | $1.1M | Sell |
8,903
-1,116
| -11% | -$139K | 0.02% | 702 |
|
|
2023
Q3 | $1.3M | Buy |
10,019
+649
| +7% | +$86.5K | 0.03% | 642 |
|
|
2023
Q2 | $1.16M | Sell |
9,370
-2,140
| -19% | -$288K | 0.02% | 688 |
|
|
2023
Q1 | $1.68M | Buy |
11,510
+1,220
| +12% | +$180K | 0.03% | 574 |
|
|
2022
Q4 | $1.64M | Buy |
10,290
+4,812
| +88% | +$705K | 0.03% | 573 |
|
|
2022
Q3 | $730K | Sell |
5,478
-275
| -5% | -$41.8K | 0.02% | 830 |
|
|
2022
Q2 | $898K | Buy |
5,753
+328
| +6% | +$50.5K | 0.02% | 789 |
|
|
2022
Q1 | $845K | Buy |
5,425
+944
| +21% | +$137K | 0.01% | 850 |
|
|
2021
Q4 | $571K | Buy |
4,481
+1,439
| +47% | +$189K | 0.01% | 966 |
|
|
2021
Q3 | $396K | Buy |
3,042
+2,218
| +269% | +$335K | 0.01% | 1077 |
|
|
2021
Q2 | $146K | Buy |
824
+588
| +249% | +$102K | ﹤0.01% | 1253 |
|
|
2021
Q1 | $39K | Sell |
236
-7
| -3% | -$1.15K | ﹤0.01% | 1426 |
|
|
2020
Q4 | $40K | Sell |
243
-16
| -6% | -$2.38K | ﹤0.01% | 1444 |
|
|
2020
Q3 | $37K | Sell |
259
-2
| -0.8% | -$248 | ﹤0.01% | 1431 |
|
|
2020
Q2 | $29K | Sell |
261
-1,941
| -88% | -$215K | ﹤0.01% | 1439 |
|
|
2020
Q1 | $220K | Sell |
2,202
-2,349
| -52% | -$304K | 0.01% | 1080 |
|
|
2019
Q4 | $679K | Sell |
4,551
-491
| -10% | -$66.8K | 0.01% | 891 |
|
|
2019
Q3 | $646K | Sell |
5,042
-2,852
| -36% | -$382K | 0.01% | 897 |
|
|
2019
Q2 | $1.13M | Sell |
7,894
-2,064
| -21% | -$277K | 0.02% | 737 |
|
|
2019
Q1 | $1.42M | Sell |
9,958
-5,286
| -35% | -$689K | 0.03% | 691 |
|
|
2018
Q4 | $1.89M | Sell |
15,244
-577
| -4% | -$85.6K | 0.04% | 528 |
|
|
2018
Q3 | $2.66M | Buy |
15,821
+1,496
| +10% | +$257K | 0.04% | 491 |
|
|
2018
Q2 | $2.47M | Sell |
14,325
-1,981
| -12% | -$324K | 0.04% | 530 |
|
|
2018
Q1 | $2.36M | Sell |
16,306
-506
| -3% | -$74.2K | 0.04% | 551 |
|
|
2017
Q4 | $2.26M | Buy |
16,812
+481
| +3% | +$66.7K | 0.04% | 576 |
|
|
2017
Q3 | $2.39M | Sell |
16,331
-1,551
| -9% | -$235K | 0.04% | 559 |
|
|
2017
Q2 | $2.78M | Buy |
17,882
+86
| +0.5% | +$13.2K | 0.05% | 507 |
|
|
2017
Q1 | $2.58M | Sell |
17,796
-5,674
| -24% | -$739K | 0.04% | 540 |
|
|
2016
Q4 | $2.56M | Sell |
23,470
-3,035
| -11% | -$338K | 0.04% | 555 |
|
|
2016
Q3 | $3.22M | Sell |
26,505
-7,691
| -22% | -$1.04M | 0.05% | 483 |
|
|
2016
Q2 | $4.83M | Sell |
34,196
-1,599
| -4% | -$236K | 0.08% | 366 |
|
|
2016
Q1 | $4.67M | Sell |
35,795
-5,126
| -13% | -$638K | 0.08% | 364 |
|
|
2015
Q4 | $5.75M | Buy |
40,921
+92
| +0.2% | +$12.7K | 0.09% | 315 |
|
|
2015
Q3 | $5.42M | Sell |
40,829
-217
| -0.5% | -$37.4K | 0.09% | 319 |
|
|
2015
Q2 | $7.23M | Buy |
41,046
+4,558
| +12% | +$819K | 0.1% | 272 |
|
|
2015
Q1 | $6.3M | Buy |
36,488
+696
| +2% | +$119K | 0.08% | 297 |
|
|
2014
Q4 | $5.86M | Buy |
35,792
+1,358
| +4% | +$225K | 0.08% | 309 |
|
|
2014
Q3 | $5.53M | Buy |
34,434
+3,112
| +10% | +$478K | 0.08% | 310 |
|
|
2014
Q2 | $4.61M | Buy |
31,322
+3,423
| +12% | +$475K | 0.06% | 355 |
|
|
2014
Q1 | $3.87M | Buy |
27,899
+5,692
| +26% | +$857K | 0.06% | 375 |
|
|
2013
Q4 | $2.81M | Buy |
22,207
+5,932
| +36% | +$614K | 0.05% | 434 |
|
|
2013
Q3 | $1.5M | Buy |
16,275
+4,770
| +41% | +$385K | 0.03% | 545 |
|
|
2013
Q2 | $791K | Buy |
+11,505
| New | +$703K | 0.01% | 692 |
|
Other funds holding JAZZ
VPM
VCM
EC
Advisors Asset Management's JAZZ Position: Q1 2026 in Review
Advisors Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 62% in Q1 2026, selling an estimated $177K and leaving 633 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1228.
Advisors Asset Management first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.23M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Advisors Asset Management held 633 shares of Jazz Pharmaceuticals worth $120K as of Q1 2026.
- Advisors Asset Management sold 1,014 Jazz Pharmaceuticals shares in Q1 2026, an estimated $177K.
- Jazz Pharmaceuticals made up ﹤0.01% of Advisors Asset Management's portfolio in Q1 2026, its #1228 holding.
- Advisors Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's Jazz Pharmaceuticals position peaked at $7.23M in Q2 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.